Interlocutory Appeals In MDLs Would Burden Litigants, Courts

By Brian Devine (April 24, 2020, 6:01 PM EDT) -- A group of pharmaceutical and medical device companies have suggested amending the Federal Rules of Civil Procedure to give them a special right to appeal interlocutory orders in multidistrict litigation cases. The proposed rule, as laid out in an April 10 Law360 guest article, would vastly diminish the long-protected right of MDL judges to manage their dockets, and burden the courts of appeal with unnecessary appeals....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!